We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK blocks Shell paying Iran oil debt in food, medicine

Mon, 22nd Apr 2013 12:44

By Richard Mably

LONDON, April 22 (Reuters) - Britain has blocked efforts byoil major Royal Dutch Shell to settle a $2.3 billiondebt it owes Iran by paying in kind with grains orpharmaceuticals, industry sources said.

Shell has been trying for months to find a way to workaround international sanctions that prevent it paying incurrency for crude it bought from the National Iranian OilCompany before a European Union embargo on Iran that startedlast July.

The sources said the British government was reluctant toprovide relief for the Iranian economy when Western powers areusing sanctions to apply financial pressure on Tehran todismantle its nuclear programme.

"The view is that doesn't make sense to smooth the way for apayment that helps Iran when government is trying to press Iranto negotiate," said an industry source.

A government spokesman declined comment on the Shell casebut said: "The government fully backs the tough regime of EUsanctions that have been put in place against Iran."

Talks earlier this month between Iran and six world powersincluding Britain failed to make progress in resolving adecade-old dispute around Iran's nuclear progress. Another roundof negotiations has been scheduled for May 21.

The industry sources said Shell in February explored withthe British government the possibility of asking Britishpharmaceuticals maker GSK to deliver medicines to Iranin a payment-in-kind deal known as an offset agreement.

GSK said it had not been approached or held any discussionson the matter. Shell declined comment.

In October, the Anglo-Dutch oil company sought permissionfor an offset agreement that would have seen U.S. agriculturaltrader Cargill deliver grain to Iran.

Following publication by Reuters, Dutch foreign ministerFrans Timmermans in a letter to parliament acknowledged theproposal, saying: "As in all sanctions regimes there are somecarefully defined exceptions applicable for which in certaincases an exemption can be granted by national governments."

Meetings were held with Cargill but, said the industrysources, the proposal was turned down by the British government.Cargill and Shell both declined comment at the time.

MAINTAINING IRAN RELATIONSHIP

The sources said the oil company wanted to repay its debt toNIOC to maintain cordial relations with Iran, one of the biggestproducers in the Organization of the Petroleum ExportingCountries.

"Politics come and go but it's in the interests of Shell andits shareholders to pay its debts and maintain a relationshipwith a leading oil producer like Iran," said one of the sources.

Shell revealed in a March filing to U.S. regulatoryauthorities that it owed Tehran $2.3 billion and made a net lossof $6 million trading Iranian oil in 2012. Unlike its rivals,Shell continued trading with Iran under a provision forpre-existing contracts close to the EU's June 30 deadline beforethe embargo. The debt is for oil purchased in 2011 and 2012.

Iran's oil revenues have fallen by about 50 percent sincesanctions were imposed last year, and regional economistsbelieve it has been forced to draw on its foreign reserves tohelp buy essentials like grains.

But with an estimated $100 billion of foreign reserves atthe start of 2012, thanks to high oil prices, the Iranianeconomy is far from collapse.

The International Monetary Fund said last week that whilesanctions had frozen Iran out of the international bankingsystem, Tehran was avoiding a balance-of-payments crisis andshould emerge from recession in 2014.

Food and medicine are among the humanitarian goods notbarred by U.S. and European sanctions but, isolated frominternational banking, Iran has been forced to pay a premium forgrain imports.

Washington has tried to restrict countries like China,India, South Korea and Japan that still buy Iranian oil topaying for shipments by the barter of approved goods - includingfood and medicine.

U.S. sanctions state that funds used to pay for oil mustremain in a bank account in the purchasing country and can beused only for non-sanctioned, bilateral trade between thatcountry and Iran. Any bank that repatriates the money ortransfers it to a third country faces a U.S. sanction risk.

Nevertheless, said the industry sources, it appears theBritish government would rather Iran be obliged to spend foreignreserves or use oil revenues to barter for essential importsthan benefit from shipments of humanitarian goods paid for byShell debt.

More News
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.